Chang-Sik Kim

Chang-Sik Kim

Auto-generated profile, based on publicly available information

Chang-Sik Kim

Department of Ophthalmology, Chungnam National University College of Medicine, Daejeon 35015, Korea

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2011 in Ophthalmology
Verified
Journal Article
Closed access
CKChang-Sik Kim
Chang-Sik Kim
GSGong Je Seong
Gong Je Seong
NLNam-Ho Lee
Nam-Ho Lee
KSKi-Chul Song
Ki-Chul Song

1 September 2009 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
ELEun-Kyoung Lee
Eun-Kyoung Lee
YYYong-Jun Yun
Yong-Jun Yun
JLJong-Eun Lee
Jong-Eun Lee
JYJin-Ho Yim
Jin-Ho Yim
CKChang-Sik Kim
Chang-Sik Kim

19 March 2008 in Clinical & Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
CKChang Sik Kim
Chang Sik Kim
JYJin Ho Yim
Jin Ho Yim
ELEun Kyoung Lee
Eun Kyoung Lee
NLNam Ho Lee
Nam Ho Lee

1 November 2012 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
KKKwangwoo Kim
Kwangwoo Kim
EBElizabeth E Brown
Elizabeth E Brown
CCChan-Bum Choi
Chan-Bum Choi
MAMarta E. Alarcón-Riquelme
Marta E. Alarcón-Riquelme
JKJennifer A Kelly
Jennifer A Kelly
SBSuk-Chul Bae
Suk-Chul Bae
Objective Systemic lupus erythematosus (SLE; OMIM 152700) is a chronic autoimmune disease for which the aetiology includes genetic and environmental factors. ITGAM, integrin αM (complement component 3 receptor 3 subunit) encoding a ligand for intracellular adhesion molecule (ICAM) proteins, is an established SLE susceptibility locus. This study aimed to evaluate the independent and joint effects of genetic variations in the genes that encode ITGAM and ICAM. Methods The authors examined several markers in the ICAM1–ICAM4–ICAM5 locus on chromosome 19p13 and the single ITGAM polymorphism (rs1143679) using a large-scale case–control study of 17 481 unrelated participants from four ancestry populations. The single-marker association and gene–gene interaction were analysed for each ancestry, and a meta-analysis across the four ancestries was performed. Results The A-allele of ICAM1–ICAM4–ICAM5 rs3093030, associated with elevated plasma levels of soluble ICAM1, and the A-allele of ITGAM rs1143679 showed the strongest association with increased SLE susceptibility in each of the ancestry populations and the trans-ancestry meta-analysis (ORmeta=1.16, 95% CI 1.11 to 1.22; p=4.88×10−10 and ORmeta=1.67, 95% CI 1.55 to 1.79; p=3.32×10−46, respectively). The effect of the ICAM single-nucleotide polymorphisms (SNPs) was independent of the effect of the ITGAM SNP rs1143679, and carriers of both ICAM rs3093030-AA and ITGAM rs1143679-AA had an OR of 4.08 compared with those with no risk allele in either SNP (95% CI 2.09 to 7.98; p=3.91×10−5). Conclusion These findings are the first to suggest that an ICAM–integrin-mediated pathway contributes to susceptibility to SLE.

1 January 2016 in Korean Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
MKMin Su Kim
Min Su Kim
KKKyoung Nam Kim
Kyoung Nam Kim
CKChang-Sik Kim
Chang-Sik Kim
Kim MS, et al. Korean J Ophthalmol. 2016 Dec;30(6):416-425. https://doi.org/10.3341/kjo.2016.30.6.416

27 October 2015 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
KKKyoung Nam Kim
Kyoung Nam Kim
SLSung Bok Lee
Sung Bok Lee
YLYeon-Hee Lee
Yeon-Hee Lee
JLJong Joo Lee
Jong Joo Lee
HLHyung Bin Lim
Hyung Bin Lim
CKChang-Sik Kim
Chang-Sik Kim
Aims To evaluate changes in the corneal endothelial cell density (ECD) and corneal decompensation following Ahmed glaucoma valve (AGV) implantation. Methods This study was retrospective and observational case series. Patients with refractory glaucoma who underwent AGV implantation and were followed >5 years were consecutively enrolled. We reviewed the medical records, including the results of central corneal specular microscopy. Of the 127 enrolled patients, the annual change in ECD (%) was determined using linear regression for 72 eyes evaluated at least four times using serial specular microscopic examination and compared with 31 control eyes (fellow glaucomatous eyes under medical treatment). The main outcome measures were cumulative risk of corneal decompensation and differences in the ECD loss rates between subjects and controls. Results The mean follow-up after AGV implantation was 43.1 months. There were no cases of postoperative tube–corneal touch. The cumulative risk of corneal decompensation was 3.3%, 5 years after AGV implantation. There was a more rapid loss of ECD in the 72 subject eyes compared with the 31 controls (−7.0% and −0.1%/year, respectively; p<0.001). However, the rate of loss decreased over time and statistical significance compared with control eyes disappeared after 2 years postoperatively: −10.7% from baseline to 1 year (p<0.01), −7.0% from 1 year to 2 years (p=0.037), −4.2% from 2 years to 3 years (p=0.230) and −2.7% from 3 years to the final follow-up (p=0.111). Conclusions In case of uncomplicated AGV implantation, the cumulative risk of corneal decompensation was 3.3%, 5 years after the operation. The ECD loss was statistically greater in eyes with AGV than in control eyes without AGV, but the difference was significant only up to 2 years post surgery.